Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities
Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe · 2024
Read Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities by Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607011.txt.
Description
Eleanor Smith and co-authors review immune therapy for cancer spread to the leptomeninges in a 2024 paper. This late-stage spread seeds cancer in the fluid and linings around the brain and cord. Outlook stays very poor, and no standard care exists. Many trials shut these patients out, so data are thin.
The review weighs systemic immune drugs, drugs given into the spinal fluid, and combined plans. Current gains look limited across the board. The immune setting of the leptomeningeal space may hold the key to better picks. Fresh work on that setting is charted. The authors call for trials that include these patients by design.
Catalog record
| CREATOR | Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |